Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma R&D Budgets And Outsourcing Are Rising
Pharmalot
Monday, October 1, 2012 - 12:28pm
tags:
R&D
Assessing Peregrine And Seeking Upside In The Space
Seeking Alpha
Monday, October 1, 2012 - 12:28pm
tags:
Peregrine Pharmaceuticals, Galena Biopharma, Roche, Sunesis
Apricus will seek Canadian MycoVa approval in 2013
Yahoo/AP
Monday, October 1, 2012 - 11:30am
tags:
Apricus, Canada, MycoVa, Onychomycosis
3 Things to Watch With Dynavax
Motley Fool
Monday, October 1, 2012 - 11:29am
tags:
Dynavax, diabetes, Heplisav
Protalix Biotherapeutics: Eyes On Elelyso Sales And Advancing Pipeline
Seeking Alpha
Monday, October 1, 2012 - 11:28am
tags:
Protalix BioTherapeutics, Elelyso, Pfizer, Sanofi, Shire, ProCellEx
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Seeking Alpha
Monday, October 1, 2012 - 11:27am
tags:
Ponatinib, CML, Ariad Pharmaceuticals, Pfizer, Bristol-Myers Squibb, Novartis
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Yahoo/Fly on the Wall
Monday, October 1, 2012 - 10:41am
tags:
Aveo Oncology, ficlatuzumab, gefitinib, non-small cell lung cancer
Celgene's Abraxane Is Talk of European Cancer Confab
TheStreet.com
Monday, October 1, 2012 - 10:39am
tags:
Celgene, Abraxane, pancreatic cancer
Threshold announces preliminary data from TH-302 study
Yahoo/Fly on the Wall
Monday, October 1, 2012 - 10:38am
tags:
Threshold Pharmaceuticals, TH-302, glioblastoma
Buy Impax Labs Before The Rytary IPX066 Train Leaves The Station
Seeking Alpha
Monday, October 1, 2012 - 10:35am
tags:
Impax Laboratories, Rytary IPX066
Horizon Pharma Announces Completion of Sales Force Expansion
Yahoo
Monday, October 1, 2012 - 10:26am
tags:
Horizon Pharma
Lilly releases Phase II results for monoclonal antibody ramucirumab
The Fly on the Wall
Monday, October 1, 2012 - 10:25am
tags:
Lilly, monoclonal antibodies, ramucirumab, lung cancer
Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say
Bloomberg
Sunday, September 30, 2012 - 10:36am
tags:
Pfizer, Xalkori, lung cancer
Peregrine: Investors are Shocked Over This Murky Future
Wall Street Cheat Street
Sunday, September 30, 2012 - 10:35am
tags:
Peregrine Pharmaceuticals
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Yahoo/MarketWire
Sunday, September 30, 2012 - 10:34am
tags:
Astellas, Medivation, Enzalutamide, prostate cancer
Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
Yahoo/MarketWire
Sunday, September 30, 2012 - 10:33am
tags:
glioblastoma, bevacizumab, TH-302, Threshold Pharmaceuticals
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Yahoo/BusinessWire
Sunday, September 30, 2012 - 10:31am
tags:
cabozantinib, Exelixis, solid tumors
Dividend? Buyback? Let's Do Both!
Motley Fool
Sunday, September 30, 2012 - 10:30am
tags:
Questcor Pharmaceuticals
Dendreon Makes Progress, but Issues May Loom
Motley Fool
Sunday, September 30, 2012 - 10:29am
tags:
Dendreon
Why the Street Should Love ViroPharma's Earnings
Motley Fool
Sunday, September 30, 2012 - 10:28am
tags:
ViroPharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.